About Us
At Mirus Bio, Innovation Never Ends
The number of applications that rely on delivery of nucleic acids into cells continues to expand and has become more diverse and complex. Replacing genes, re-programming T cells, producing novel biologics, and silencing mRNA translation, are just some of the noteworthy advances that depend on successful transfection.
That’s why we never stop innovating.
One Size Does Not Fit All
Each of these applications is unique and requires a transfection solution that is intentionally designed to deliver nucleic acid into a variety of cell types – consistently and efficiently.
Since our founding in 1995, we’ve been up to the challenge.
>40K
USERS
In both the biopharmaceutical and research industries
>10K
PUBLICATIONS
Published in over 10,000 peer-reviewed publications
>1.2K
CELL LINES
Over 1,200 cell lines in which products have been used
56
PATENTS
56 U.S. and International
patents granted
A Legacy of Transfection Innovation
Since its founding in 1995, Mirus Bio has been meeting industry and customer needs through innovation, collaboration and partnerships.